PUNE, India, September 30, 2016 /PRNewswire/ --
According to a new market research report
"Point-of-Care Diagnostics Market by Products (Glucose,
Cardiometabolic Monitoring, & Infectious Disease Testing Kits,
Cardiac & Tumor Markers), End Users (Home, Hospitals,
Ambulatory Care), Over-the- Counter & Prescription Based -
Global Forecast to 2021 ", published by
MarketsandMarkets, analyzes and studies the major market drivers,
restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world
(RoW).
(Logo:
http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 94 market data Tables and 55 Figures spread through
221 Pages and in-depth TOC on "Point-of-Care Diagnostics
Market"
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html
Early buyers will receive 10% customization
on this report.
This report studies the global point-of-care diagnostics market
over the forecast period of 2016 to 2021. The market is expected to
reach USD 36.96 Billion by 2021, at
CAGR of 9.8% from 2016 to 2021.
On the basis of product, the global point-of-care diagnostics
market is divided into 12 major segments, namely, glucose
monitoring kits, infectious diseases testing kits, cardiometabolic
monitoring kits, coagulation monitoring kits, hematology testing
kits, urinalysis testing kits, cholesterol test strips,
drugs-of-abuse testing kits, tumor/cancer markers, pregnancy and
fertility testing kits, fecal occult testing kits, and other
products. Other products segment comprises of multi-assay testing
kits and vitamin assay testing kits. The glucose monitoring kits
segment is estimated to hold the largest share of the POC
diagnostics market in 2016. Increasing number of POC glucose
monitoring devices coupled with growing incidences and prevalence
of diabetes across the globe are factors driving the growth of this
market segment.
Based on mode of prescription, the global point-of-care
diagnostics market is segmented as prescription based testing kits
and over-the-counter (OTC) testing kits. The OTC testing kits are
expected to witness higher growth in the market during the forecast
period. The global point-of-care diagnostics market is also divided
into four segments by type of end user-- professional diagnostics,
research laboratories, home care, and other end-users.
Key factors such as prevalence of lifestyle and infectious
diseases and the increasing inclination toward home healthcare
across the globe are driving the growth of the point-of-care
diagnostics market, globally. In addition, private investments and
venture funding towards the development of new products along with
the growing government support to increase the adoption of POC
devices are boosting market growth. On the other hand, the
reluctance among patients to change existing treatment practices is
one of the key factors hampering the growth of the point-of-care
diagnostics market.
As of 2016, North America holds
the largest share of the global point-of-care diagnostics market,
followed by Europe. However, the
Asia-Pacific market is expected to
grow at the highest CAGR of 14.2% from 2016 to 2021. A number of
factors such as growing initiatives by market players for expanding
their distribution network, increasing patient population base, and
rising number of partnerships and joint ventures among POC
providers are propelling the growth of the Asia-Pacific point-of-care diagnostics
market.
Ask for PDF Brochure:
http://www.marketsandmarkets.com/pdfdownload.asp?id=106829185
Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited
(Switzerland), Siemens AG
(Germany), Beckman Coulter, Inc. (U.S.), Becton, Dickinson
and Company (U.S.), Johnson & Johnson (U.S.), Alere Inc.
(U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.),
and Nova Biomedical (U.S.) are some of the key players operating in
the point-of-care diagnostics market.
Browse Related
Reports:
In Vitro Diagnostics (IVD) Market by Product
(instruments, Reagents, Software, Service) Technology (Immunoassay,
Clinical Chemistry, Molecular Diagnostics, Hematology) by
Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) -
Forecast to 2020
http://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html
Coagulation/Hemostasis Analyzer Market by Product
(Automated, POC), Consumables (Reagents, Standards), Test Type
(APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology
(Mechanical, Optical), End Users (Research Institutes, Hospitals) -
Forecast to 2019
http://www.marketsandmarkets.com/Market-Reports/hemostasis-coagulation-analyzer-market-197226392.html
About MarketsandMarkets
MarketsandMarkets is the largest market research firm worldwide
in terms of annually published premium market research reports.
Serving 1700 global fortune enterprises with more than 1200 premium
studies in a year, M&M is catering to a multitude of clients
across 8 different industrial verticals. We specialize in
consulting assignments and business research across high growth
markets, cutting edge technologies and newer applications. Our 850
fulltime analyst and SMEs at MarketsandMarkets are tracking global
high growth markets following the "Growth Engagement Model - GEM".
The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers,
write "Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research
platform, "RT" connects over 200,000 markets and entire value
chains for deeper understanding of the unmet insights along with
market sizing and forecasts of niche markets. The new included
chapters on Methodology and Benchmarking presented with high
quality analytical infographics in our reports gives complete
visibility of how the numbers have been arrived and defend the
accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence
repository.
Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
Telephone No: 1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @
http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn
@ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets